Incident psychotic experiences following self‐reported use of high‐potency cannabis: Results from a longitudinal cohort study
Addiction · 2024
DOI: 10.1111/add.16517 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Addiction, 2024. Verfasst von Lindsey A Hines und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. Hauptthemen laut MEDLINE: Self Report, Psychoses, Substance-Induced. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, UK Medical Research Council and Wellcome Trust.
Abstract (Originalsprache)
Background and aims High‐potency cannabis has been associated with increased risk of psychosis, but a lack of prospective data hinders understanding of causality in this relationship. This study aimed to combine prospective report of cannabis use with retrospective report of potency to infer the potency of cannabis used in adolescence and explore whether use of cannabis, and the use of high‐potency cannabis, in adolescence is associated with incident psychotic experiences.
Design
Population‐based birth cohort study.
Setting
United Kingdom. Participants n = 5570 participants who reported on any cannabis use (yes/no) age 16 and 18 years, and n = 1560 participants from this group who also retrospectively reported on cannabis potency.
Measurements
In questionnaires at ages 16 and 18, individuals self‐reported lifetime cannabis use, and at age 24, participants reported the type of cannabis they most commonly used in the whole time since first using cannabis. Psychotic experiences were assessed at age 24 years using the semi‐structured Psychosis‐Like Symptom Interview, with incident defined as new‐onset occurring between ages 19 and 24 years.
Findings
Use of high‐potency cannabis at age 16 or 18 was associated with twice the likelihood of experiencing incident psychotic experiences from age 19–24 (Odds Ratio 2.15, 95% Confidence Intervals 1.13–4.06). There was less evidence for an effect of any cannabis use on incident psychotic experiences (Odds Ratio 1.45, 95% Confidence Intervals 0.94–2.12).
Conclusions
Use of high‐potency cannabis appears to be associated with increased likelihood of psychotic experiences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- Department of Psychology, University of Bath, Bath, UK.
- Medical Research Council (MRC) Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK.
ORCID-Profile: Lindsey A Hines
Förderung
- Medical Research Council
- Wellcome Trust
- UK Medical Research Council and Wellcome Trust
Zitieren
APA
Hines, L. A., Heron, J., & Zammit, S. (2024). Incident psychotic experiences following self‐reported use of high‐potency cannabis: Results from a longitudinal cohort study. Addiction. https://doi.org/10.1111/add.16517
Vancouver
Hines LA, Heron J, Zammit S. Incident psychotic experiences following self‐reported use of high‐potency cannabis: Results from a longitudinal cohort study. Addiction. 2024. doi:10.1111/add.16517
BibTeX
@article{Hines2024,
author = {Hines, Lindsey A and Heron, Jon and Zammit, Stanley},
title = {Incident psychotic experiences following self‐reported use of high‐potency cannabis: Results from a longitudinal cohort study},
journal = {Addiction},
year = {2024},
doi = {10.1111/add.16517}
}
EUVIMED